Criteria for diagnosis and classification of vascular cognitive impairment
https://doi.org/10.14412/2074-2711-2022-6-131-138
Abstract
Vascular cognitive impairment (VCI) is a very diverse group of conditions that differ in etiopathogenesis, severity, clinical picture, dynamics and severity of functional disorders. This heterogeneity significantly complicates the development of uniform standardized recommendations for the diagnosis and treatment of VCI. The development of criteria for each clinical and pathogenetic variant for permanent practical application is a difficult task. In this article, based on the analysis of previously proposed approaches to the diagnosis of various clinical and pathogenetic variants, common diagnostic criteria and classification of VCI are presented.
About the Authors
A. Y. Emelin
Department of Nervous System Diseases, S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
Competing Interests:
Russian Federation
Andrey Yuryevich Emelin
194044, St. Petersburg, Academician Lebedev St., 6
Competing Interests:
There are no conflicts of interest.
V. Y. Lobzin
Department of Nervous System Diseases, S.M. Kirov Military Medical Academy, Ministry of Defense of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia; Children's Scientific and Clinical Center for Infectious Diseases of the Federal Medical and Biological Agency of Russia
Russian Federation
Competing Interests:
Russian Federation
194044, St. Petersburg, Academician Lebedev St., 6
191015, St. Petersburg, Kirochnaya St., 41
197022, St. Petersburg, Professor Popov St., 9
Competing Interests:
There are no conflicts of interest.
References
1. Odinak MM, Emelin AYu, Lobzin VYu. Narusheniye kognitivnykh funktsiy pri tserebrovaskulyarnoy patologii [Impairment of cognitive functions in cerebrovascular pathology]. St. Petersburg: SpecLit; 2022. 229 p. (In Russ.).
2. Damulin IV. Cognitive disorders in cerebrovascular pathology. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2009;(1):70-5 (In Russ.).
3. Wu YT, Fratiglioni L, Matthews F, et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016 Jan;15(1):116-24. doi:10.1016/S1474-4422(15)00092-7. Epub 2015 Aug 21.
4. Erkinjuntti T. Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl. 2002;(63):91-109. doi:10.1007/978-3-7091-6137-1_6
5. Roman GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc. 2003 May;51(5 Suppl Dementia):S296-304. doi:10.1046/j.1532-5415.5155.x
6. Gorelick P, Scuteri A, Black S, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672-713. doi:10.1161/STR.0b013e3182299496
7. Jessen F, Amariglio R, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease Alzheimers Dement. 2014 Nov;10(6):844-52. doi:10.1016/j.jalz.2014.01.001. Epub 2014 May 3.
8. Emelin AYu. Cognitive impairments in cerebrovascular disease. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2014;6(4):11-8. doi:10.14412/2074-2711-2014-4-11-18 (In Russ.).
9. Emelin AYu, Lobzin VYu, Vorobyov SV. Kognitivnyye narusheniya: rukovodstvo dlya vrachey [Cognitive impairment: a guide for physicians]. Moscow; 2019. 416 p. (In Russ.).
10. Inzitari D, Marinoni M, Ginanneschi A. Pathophysiology of leucoaraiosis. New concepts in vascular dementia. Barcelona: Prous Science Publishers; 1993. P. 103-13.
11. Roman G, Tatemichi T, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDSAIREN International Workshop. Neurology. 1993 Feb;43(2):250-60. doi:10.1212/wnl.43.2.250
12. Gold G, Bouras C, Canuto A, et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry. 2002 Jan;159(1):82-7. doi:10.1176/appi.ajp.159.1.82
13. Rockwood K, Wentzel C, Hachinski V, et al. Prevalence and outcomes of vascular cognitive impairment. Neurology. 2000 Jan 25;54(2):447-51. doi:10.1212/wnl.54.2.447
14. Roman G, Sachdev P, Royall D, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci. 2004 Nov 15;226(1-2):81-7. doi:10.1016/j.jns.2004.09.016
15. Barbay M, Taillia H, Nedelec-Ciceri C, et al; GRECOG-VASC Study Group. Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit. Stroke. 2018 May;49(5):1141-7. doi:10.1161/STROKEAHA.117.018889. Epub 2018 Apr 11.
16. Sachdev P, Kalaria R, O'Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):206-18. doi:10.1097/WAD.0000000000000034
17. Hachinski V, Iadecola C, Petersen R, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006 Sep;37(9):2220-41. doi:10.1161/01.STR.0000237236.88823.47. Epub 2006 Aug 17.
18. Sachdev P, Brodaty H, Valenzuela M, et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology. 2004 Mar 23;62(6):912-9. doi:10.1212/01.wnl.0000115108.65264.4b
19. Skrobot O, O'Brien J, Black S, et al. The Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2017 Jun;13(6):624-33. doi:10.1016/j.jalz.2016.10.007. Epub 2016 Dec 10.
20. Wardlaw J, Smith E, Biessels G, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Lancet Neurol. 2013;12(8):822-38. doi:10.1016/S1474-4422(13)70124-8
21. Schneider J, Wilson JR, Cochran E, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003 Apr 8;60(7):1082-8. doi:10.1212/01.wnl.0000055863.87435.b2
22. Sonnen J, Larson E, Crane P, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol. 2007 Oct;62(4):406-13. doi:10.1002/ana.21208
23. Gorelick PB, Nyenhuis D. Stroke and cognitive decline. JAMA. 2015 Jul 7;314(1):29-30. doi:10.1001/jama.2015.7149
24. Parfenov VA. Combination and mutual effect of Alzheimer's disease and cerebrovascular disease. Meditsinskiy sovet = Medical Council. 2019;(9):8-13. doi:10.21518/2079-701X-2019-9-8-13 (In Russ.).
25. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007 Dec 11;69(24):2197-204. doi:10.1212/01.wnl.0000271090.28148.24. Epub 2007 Jun 13.
26. Vemuri P, Lesnick T, Przybelski S, et al. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain. 2015 Mar;138(Pt 3):761-71. doi:10.1093/brain/awu393. Epub 2015 Jan 15.
27. McAleese K, Alafuzoff I, Charidimou A, et al. Post-mortem assessment in vascular dementia: advances and aspirations. BMC Medicine. 2016 Aug 26;14(1):129. doi:10.1186/s12916-016-0676-5
28. Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral small vessel disease: a road map on key definitions and current concepts. Int J Stroke. 2016 Jan;11(1):6-18. doi:10.1177/1747493015607485
29. Verbitskaya SV, Parfenov VA, Reshetnikov VA, et al. Post-stroke cognitive impairment (results of a 5-year follow-up). Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):37-42. doi:10.14412/2074-2711-2018-1-37-42 (In Russ.).
30. Tatemichi T, Desmond D, Prohovnik I. Strategic infarcts in vascular dementia. A clinical and brain imaging experience. Arzneimittelforschung. 1995 Mar;45(3A):371-85.
31. Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. doi:10.14412/2074-2711-2018-3-4-11 (In Russ.).
32. Litvinenko IV, Emelin AYu, Lobzin VYu, Kolmakova KA. Neuroimaging techniques for diagnosing Alzheimer's disease and cerebrovascular diseases with cognitive impairment. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):18-25. doi:10.14412/2074-2711-2019-3S-18-25 (In Russ.).
33. Benedictus M, Hochart A, Rossi C, et al. Prognostic factors for cognitive decline after intracerebral hemorrhage. Stroke. 2015 Oct;46(10):2773-8. doi:10.1161/STROKEAHA.115.010200. Epub 2015 Aug 13.
34. Moulin S, Labreuche J, Bombois S, et al. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol. 2016 Jul;15(8):820-9. doi:10.1016/S1474-4422(16)00130-7. Epub 2016 Apr 28.
35. Balestrini S, Perozzi C, Altamura C, et al. Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration. Neurology. 2013 Jun 4;80(23):2145-50. doi:10.1212/WNL.0b013e318295d71a. Epub 2013 Apr 26.
36. Jellinger K. Pathology and pathogenesis of vascular cognitive impairment – a critical update. Front Aging Neurosci. 2013 Apr 10;5:17. doi:10.3389/fnagi.2013.00017. eCollection 2013.
37. Yakhno NN, Lokshina AB, Zakharov VV. Mild and moderate cognitive impairment in dyscirculatory encephalopathy. Klinicheskaya gerontologiya. 2005;11(9):38-9 (In Russ.).
Review
For citations:
Emelin AY, Lobzin VY. Criteria for diagnosis and classification of vascular cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(6):131-138. (In Russ.) https://doi.org/10.14412/2074-2711-2022-6-131-138
Views:
589
Email this article 